Six donor-conceived children remain untested, Denmark still chases cancer warning after 2.5 years, families wait outside follow-up system

• DR reports that six Danish children remain untested despite a donor warning issued more than 2.5 years ago.
• The warning concerned a hereditary condition linked to elevated cancer risk in children conceived with sperm from the donor.
• The case has raised questions about how many children were affected and why some families still have not completed basic follow-up testing.
• A leading clinical geneticist told DR the warning may still not have reached everyone.

Six Danish children are still untested more than two and a half years after authorities were alerted to a possible hereditary cancer risk linked to a sperm donor, according to DR reports. The children were conceived with sperm from the same donor, and the unresolved cases remain open long after the original warning was supposed to trigger tracing, notification and genetic follow-up.

DR writes that the warning concerned a genetic variant that can increase the risk of cancer. A leading Danish clinical geneticist told the broadcaster that the message may still not have reached all affected families. That leaves a basic question hanging over the case: how many children were exposed, how many have been contacted, and why are six still outside the testing process after such a long interval. When the risk is known, the delay is no longer about discovery but about administration.

The case reaches beyond one donor and one clinic. Denmark has built a large fertility sector that serves both domestic and foreign patients, which makes donor tracing and downstream responsibility more than a paperwork exercise. A donor can result in children across multiple families and jurisdictions; once a medical warning appears, every missing record and every delayed contact compounds the problem. The system is designed to offer anonymity rules, medical screening and central handling of donor information. This case shows the other side of that design: when follow-up depends on institutions passing information from registry to clinic to family, children can wait years for a test that takes far less time than the correspondence around it.

DR’s reporting also points to a narrower failure with wider consequences. If six children in Denmark alone remain untested after 2.5 years, then the bottleneck is not the rarity of the risk but the speed of the response. Parents cannot act on a warning they have not received, and doctors cannot test children who never enter the follow-up chain. The result is a protection system that exists on paper while some of the children it was built for are still being located.

For families, the practical issue is plain: a known donor warning was issued, yet some children are still waiting to be checked. More than two and a half years later, six Danish children remain a list of names that the system has not finished reaching.

Källor: DR Nyheder